At a glance
ClinicalIndex Comparison RecordN/ACompleted· 91 enrolled
Drug / intervention
Facemask preoxygenation +1 moredevice
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Preoxygenation Using THRIVE and Facemask Oxygenation in Parturients
In Brief
A clinical study evaluating Facemask preoxygenation and THRIVE preoxygenation for Preoxygenation. Completed, enrolled 91 participants across 1 site.
Detailed Summary
This study aims to determine the duration for pre-oxygenation using THRIVE and facemask for parturients.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPreoxygenation
CountriesCanada
Collaborators--
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartDec 2018
First PostedDec 2018
Primary CompletionJul 2019
Study CompletionApr 2020
TodayJul 2026
First PostedDec 11, 2018
Enrollment StartDec 1, 2018
Primary CompletionJul 15, 2019
Study CompletionApr 24, 2020
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 7.6 years ago
Interventions
Facemask preoxygenationdevice
Standard facemask preoxygenation
THRIVE preoxygenationdevice
Preoxygenation using transnasal humidified rapid insufflation ventilatory exchange (THRIVE).